Biotechs continued rushing to finalize deals before the year-end, with Human Genome Sciences Inc. and Montreal-based Aegera Therapeutics Inc. teaming up in a $315 million agreement to develop and commercialize cancer cell-killing molecules. (BioWorld Today)

BioWorld's offices will be closed Monday, Dec. 24, and Tuesday, Dec. 25, in observance of the Christmas holiday in the U.S. No issues will be published those days.